Skip to main content

Table 1 Hematologic parameters at baseline, following change to imatib and return to imatinib therapy

From: Failure of a non-authorized copy product to maintain response achieved with imatinib in a patient with chronic phase chronic myeloid leukemia: a case report

Laboratory value

January 2007Imatinib 400 mg/day

March 2007Imatib 400 mg/day

July 2007Imatinib 600 mg/day

Red blood cell count (n/mm3)

4,850,000

3,200,000

4,200,000

Hemoglobin (g/dL)

13.4

9

12.7

Total leukocyte count (n/mm3)

4200

2300

3800

Neutrophils

68%

34%

66%

Eosinophils

1%

7%

2%

Basophils

1%

8%

2%

Lymphocytes

24%

41%

25%

Monocytes

6%

10%

5%

Platelet count (n/mm3)

234,000

101,000

156,000